Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT immunogenicity and safety study in toddlers
PACTR201408000864165Not yet recruiting
- Sponsor
- GSK
- Start
- Aug 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine and pneumococcal 13-valent conjugate vaccine in meningococcal disease (4 arms), sponsored by GSK. Planned start Aug 2014; status: not yet recruiting.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on PACTR201408000864165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201408000864165.